Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated Qiongshao capsule and atorvastatin intervention for vulnerable coronary artery plaque
ChiCTR-TRC-06000007Phase 4Completed
- Sponsor
- Beijing An Zhen Hospital
- Start
- Jun 2006
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of atorvastatin and QiongShao capsule in coronary arteriosclerosis and unstable angina (3 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Change of the plaque type by IVUS quantitative and qualitative indices. Started Jun 2006; status: completed.
02
Drugs
atorvastatinQiongShao capsule
03
Conditions
coronary arteriosclerosisunstable angina
Beyond the preview
Go deeper on ChiCTR-TRC-06000007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-06000007.